Andrews R, Jorge R, Christie R, Gallegos A (2023) From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day. Drug Test Anal 15(4):378–387. https://doi.org/10.1002/dta.3422

Article  CAS  PubMed  Google Scholar 

Apirakkan O, Gavrilovic I, Cowan DA, Abbate V (2020) In vitro Phase I metabolic profiling of the synthetic cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA. Chem Res Toxicol 33(7):1653–1664. https://doi.org/10.1021/acs.chemrestox.9b00466

Article  CAS  PubMed  Google Scholar 

Brown JD, Rivera Rivera KJ, Hernandez LYC et al (2021) Natural and synthetic cannabinoids: pharmacology, uses, adverse drug events, and drug interactions. J Clin Pharmcol 61:37–52

Google Scholar 

Bukke VN, Archana M, Villani R, Serviddio G, Cassano TJP (2021) Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing Risk Public Health. Pharmaceuticals 14(10):965

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA (2014) Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 144:12–41. https://doi.org/10.1016/j.drugalcdep.2014.08.005

Article  CAS  PubMed  Google Scholar 

Castaneto MS, Wohlfarth A, Desrosiers NA, Hartman RL, Gorelick DA, Huestis MAJDmr (2015) Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metab Rev 47(2):124–174

Article  CAS  PubMed  Google Scholar 

Cohen K, Weinstein AM (2018) Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Front Public Health 6:162. https://doi.org/10.3389/fpubh.2018.00162

Article  PubMed  PubMed Central  Google Scholar 

Diao X, Huestis MA (2019) New synthetic cannabinoids metabolism and strategies to best identify optimal marker metabolites. Front Chem 7:109. https://doi.org/10.3389/fchem.2019.00109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giorgetti A, Busardo FP, Tittarelli R, Auwarter V, Giorgetti R (2020) Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists. Front Psychiatry 11:464. https://doi.org/10.3389/fpsyt.2020.00464

Article  PubMed  PubMed Central  Google Scholar 

Giorgetti A, Brunetti P, Haschimi B, Busardo FP, Pelotti S, Auwarter V (2023) Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA. Drug Test Anal 15(3):299–313. https://doi.org/10.1002/dta.3405

Article  CAS  PubMed  Google Scholar 

Hasin DS, Saha TD, Kerridge BT et al (2015) Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiat 72(12):1235–1242. https://doi.org/10.1001/jamapsychiatry.2015.1858

Article  Google Scholar 

Holm NB, Pedersen AJ, Dalsgaard PW, Linnet K (2015) Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry. Drug Test Anal 7(3):199–206. https://doi.org/10.1002/dta.1663

Article  CAS  PubMed  Google Scholar 

Jones S, Yarbrough AL, Fantegrossi WE et al (2020) Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacol Res Perspect 8(1):e00561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kavanagh P, Pechnikov A, Nikolaev I, Dowling G, Kolosova M, Grigoryev A (2022) Detection of ADB-BUTINACA metabolites in human urine, blood kidney and liver. J Anal Toxicol 46(6):641–650. https://doi.org/10.1093/jat/bkab088

Article  CAS  PubMed  Google Scholar 

Krotulski AJ, Cannaert A, Stove C, Logan BKJDT, Analysis (2021) The next generation of synthetic cannabinoids: detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA. Drug Test Anal 13(2):427–438

Article  CAS  PubMed  Google Scholar 

Kusano M, Zaitsu K, Taki K et al (2018) Fatal intoxication by 5F-ADB and diphenidine: detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS. Drug Test Anal 10(2):284–293. https://doi.org/10.1002/dta.2215

Article  CAS  PubMed  Google Scholar 

Lee KZH, Wang Z, Fong CY, Goh EML, Moy HY, Chan ECY (2022) Identification of optimal urinary biomarkers of synthetic cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for illicit abuse monitoring. Clin Chem 68(11):1436–1448. https://doi.org/10.1093/clinchem/hvac138

Article  PubMed  Google Scholar 

Meng X, Hua Z, Jia W, Liu C, Liu S, Chen YJFyxzz (2021) Identification of synthetic cannabinoid 5F-EDMB-PICA in suspicious herbal products. J Forensic Med 37(4):486–492

CAS  Google Scholar 

Mills B, Yepes A, Nugent K (2015) Synthetic cannabinoids. Am J Med Sci 350(1):59–62. https://doi.org/10.1097/MAJ.0000000000000466

Article  PubMed  Google Scholar 

Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153(2):199–215. https://doi.org/10.1038/sj.bjp.0707442

Article  CAS  PubMed  Google Scholar 

Tournebize J, Gibaja V, Kahn JP (2017) Acute effects of synthetic cannabinoids: update 2015. Subst Abus 38(3):344–366. https://doi.org/10.1080/08897077.2016.1219438

Article  PubMed  Google Scholar 

Walle N, Nordmeier F, Doerr AA et al (2021) Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7-azaindole-derived synthetic cannabinoids exemplified using cumyl-5F-P7AICA. Drug Test Anal 13(1):74–90. https://doi.org/10.1002/dta.2899

Article  CAS  PubMed  Google Scholar 

Watanabe S, Vikingsson S, Astrand A, Green H, Kronstrand R (2019) Biotransformation of the new synthetic cannabinoid with an alkene, MDMB-4en-PINACA, by human hepatocytes, human liver microsomes, and human urine and blood. AAPS J 22(1):13. https://doi.org/10.1208/s12248-019-0381-3

Article  CAS  PubMed  Google Scholar 

Watanabe S, Yamane H, Iwai T, Matsushita R, Seto Y (2023) In vitro metabolic profiling of new synthetic cannabinoids, ADB-FUBIATA, AFUBIATA, CH-FUBIATA, and CH-PIATA. Arch Toxicol 97(12):3085–3094. https://doi.org/10.1007/s00204-023-03605-1

Article  CAS  PubMed  Google Scholar 

Wohlfarth A, Gandhi AS, Pang S, Zhu M, Scheidweiler KB, Huestis MA (2014) Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal Bioanal Chem 406(6):1763–1780. https://doi.org/10.1007/s00216-014-7668-0

Article  CAS  PubMed  Google Scholar 

Xu F, Wei W, Shan X, Wang R, Liu LJFT (2022) Identification and characterization of novel synthetic cannabinoid ethyl-2-(1-(5-fluoropentyl)-1 H-indole-3-carboxamido)-3, 3-dimethylbutanoate (5F-EDMB-PICA). Forensic Toxicol 1–10